Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Epstein-Barr virus mRNAs produced by alternative splicing.

M Bodescot, M Perricaudet

    Nucleic Acids Research
    |September 11, 1986
    PubMed
    Summary

    Epstein-Barr virus mRNAs exhibit complex alternative splicing from a single promoter, creating diverse structures. These transcripts, including those for Epstein-Barr nuclear antigen 1 (EBNA-1), feature unusually long 5' untranslated regions.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Third-generation adenovectors for gene therapy.

    Restorative neurology and neuroscience·2011
    Same author

    Using adenoviral vectors to transfer the CNTF gene into the CNS.

    Restorative neurology and neuroscience·2011
    Same author

    Transplantation of cells genetically modified and direct intracerebral gene transfer with an adenoviral vector expressing tyrosine hydroxylase in a rat model of Parkinson's disease.

    Restorative neurology and neuroscience·2011
    Same author

    The soluble fragment of VE-cadherin inhibits angiogenesis by reducing endothelial cell proliferation and tube capillary formation.

    Cancer gene therapy·2010
    Same author

    Efficient delivery of angiostatin K1-5 into tumors following insertion of an NGR peptide into adenovirus capsid.

    Gene therapy·2009
    Same author

    Canstatin gene electrotransfer combined with radiotherapy: preclinical trials for cancer treatment.

    Gene therapy·2008

    Area of Science:

    • Virology
    • Molecular Biology
    • Genomics

    Background:

    • Epstein-Barr virus (EBV) is a human herpesvirus implicated in various cancers.
    • Understanding EBV gene expression is crucial for deciphering its oncogenic potential.

    Purpose of the Study:

    • To elucidate the structural organization of Epstein-Barr virus mRNAs.
    • To analyze the alternative splicing patterns and identify potential coding regions.

    Main Methods:

    • cDNA cloning and sequencing of EBV transcripts from B95-8 cells.
    • Analysis of exon-intron boundaries and open reading frames.

    Main Results:

    • Four distinct EBV mRNA species were identified, originating from a single promoter in the US region.
    • Alternative splicing of exons from US, IR, and UL regions, spanning over 100 kbp.
    • Identified unusually long 5' untranslated regions in the mRNAs.
    • Three mRNA species potentially encode the nuclear antigen EBNA-1.

    Conclusions:

    • EBV employs complex alternative splicing to generate diverse mRNA structures.
    • The identified mRNA structures suggest varied protein products, including EBNA-1.
    • Further research is needed to determine the functions of the encoded polypeptides.

    Related Experiment Videos